Please assess the completion status of the following clinical trial:

Trial Title: Study Of AG-013736 (Axitinib) In Patients With Advanced Solid Tumors

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients histologically or cytologically diagnosed with advanced malignant solid tumors~* Patients for whom standard therapies have not been effective, or for whom there are no suitable therapies~Exclusion Criteria:~* Central lung lesions involving major blood vessels~* Patients who have been treated with bevacizumab or other VEGFR inhibitor(s)

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Open (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).